Medical Data Vision Dirección

Dirección controles de criterios 1/4

We currently do not have sufficient information about the CEO.

Información clave

Hiroyuki Iwasaki

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	10.2yrs
Participación del CEO	2.1%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	8.7yrs

Actualizaciones recientes de la dirección

Recent updates

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Jun 25

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Jun 13

CEO

Hiroyuki Iwasaki (64 yo)

10.2yrs

Permanencia

Mr. Hiroyuki Iwasaki has been the President and Representative Director of Medical Data Vision Co., Ltd. since September 2014 and serves as its Chairman. Mr. Hiroyuki Iwasaki joined Shin Nihonkokan Co., Lt...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Hiroyuki Iwasaki	Chairman & President	10.2yrs	sin datos	2.1% ¥ 417.1m
Syuuji Asami	Senior MD	21.3yrs	sin datos	0.23% ¥ 46.5m
Takuji Yanagisawa	GM of Business Planning Division	16.3yrs	sin datos	0.22% ¥ 42.8m
Masaki Nakamura	GM of the Alliance Promotion Office & Director	6.7yrs	sin datos	0.0034% ¥ 682.6k
Soichi Katsuki	Independent Outside Director	8.7yrs	sin datos	0.042% ¥ 8.3m
Kiyohito Hamada	Independent Outside Audit & Supervisory Board Member	10.7yrs	sin datos	sin datos
Osamu Nakagawa	Audit & Supervisory Board Member	11.7yrs	sin datos	sin datos
Takao Nakamura	Independent Outside Director	5.7yrs	sin datos	sin datos
Yasunori Matsumoto	Independent Outside Audit & Supervisory Board Member	6.7yrs	sin datos	sin datos
Masaaki Takaki	Independent Outside Full-Time Audit & Supervisory Board Member	2.7yrs	sin datos	sin datos
Kiyomi Nojiro	Independent Outside Director	less than a year	sin datos	sin datos

8.7yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: 3902's board of directors are considered experienced (8.7 years average tenure).

Medical Data Vision Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 27, 2024

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 28, 2023

Less than half of directors are independent

Less than half of directors are independent

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 29, 2022

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 23, 2021

Recent updates

Medical Data Vision (TSE:3902) Will Pay A Dividend Of ¥6.50

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 2,000,000 shares, representing 5.24% for ¥1,000 million.

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Medical Data Vision Co., Ltd. to Report Q3, 2024 Results on Nov 11, 2024

New minor risk - Profit margin trend

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Dividend of JP¥6.50 announced

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Medical Data Vision Co., Ltd. to Report Q2, 2024 Results on Aug 08, 2024

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

New minor risk - Share price stability

First quarter 2024 earnings released: JP¥0.39 loss per share (vs JP¥7.20 profit in 1Q 2023)

Now 21% overvalued

Now 22% overvalued

Medical Data Vision Co., Ltd. to Report Q1, 2024 Results on May 13, 2024

Full year 2023 earnings released: EPS: JP¥25.63 (vs JP¥22.75 in FY 2022)

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 27, 2024

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Medical Data Vision Co., Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥6.50 per share at 1.1% yield

Now 23% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: JP¥5.60 (vs JP¥6.65 in 3Q 2022)

Now 21% undervalued after recent price drop

Medical Data Vision Co., Ltd. to Report Q3, 2023 Results on Nov 13, 2023

Now 23% undervalued after recent price drop

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: JP¥4.45 (vs JP¥5.47 in 2Q 2022)

Price target decreased by 14% to JP¥815

Medical Data Vision Co., Ltd. to Report Q2, 2023 Results on Aug 10, 2023

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

First quarter 2023 earnings released: EPS: JP¥7.20 (vs JP¥8.16 in 1Q 2022)

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2023

Price target decreased by 15% to JP¥1,010

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 28, 2023

Medical Data Vision Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023

Upcoming dividend of JP¥6.00 per share

Less than half of directors are independent

Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2022

Medical Data Vision Co., Ltd. to Report Q3, 2022 Results on Nov 14, 2022

Medical Data Vision Provides Dividend Guidance for the Fiscal Year Ending December 31, 2022

Second quarter 2022 earnings released: EPS: JP¥5.47 (vs JP¥4.47 in 2Q 2021)

Medical Data Vision Co., Ltd. to Report Q2, 2022 Results on Aug 08, 2022

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Price target decreased to JP¥1,220

Less than half of directors are independent

Medical Data Vision Co., Ltd. to Report Q1, 2022 Results on May 12, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 29, 2022

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 800,000 shares, representing 2.05% for ¥1,000 million.

Upcoming dividend of JP¥5.00 per share

Price target decreased to JP¥2,275

Third quarter 2021 earnings released: EPS JP¥5.49 (vs JP¥5.28 in 3Q 2020)

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 200,000 shares, representing 0.51% for ¥345 million.

Second quarter 2021 earnings released: EPS JP¥4.47 (vs JP¥4.26 in 2Q 2020)

First quarter 2021 earnings released: EPS JP¥7.84 (vs JP¥3.80 in 1Q 2020)

New 90-day low: JP¥2,031

Analysts lower EPS estimates to JP¥20.80

Full year 2020 earnings released: EPS JP¥17.72 (vs JP¥13.84 in FY 2019)

Revenue and earnings miss expectations

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 23, 2021